Rospotrebnadzor spoke about the condition of those testing the vaccine against COVID-19

“All volunteers vaccinated with the EpiVacCorona vaccine are doing well. No complications or complaints were noted, "RIA Novosti reports.

As specified, four volunteers are vaccinated, the fifth will receive the vaccine on August 8, three days later the next nine people will receive it.

In the second phase of the clinical study, 43 of 86 volunteers will receive a placebo.

Earlier, Rospotrebnadzor said that the Vector Center, when developing the EpiVacCorona vaccine, takes into account all the requirements and regulatory recommendations provided for by Russian legislation.